Avoiding Unintended Consequences of Changes (com)

Added by Albert Jones on 2019-03-06

Conference Dates:

Start Date Start Date: 2019-04-11
Last Date Last Day: 2019-04-12

Conference Contact Info:

Contact Person Contact Person: Marilyn. B. Turner
Email Email: [email protected]
Address Address: DoubleTree by Hilton Hotel Boston Downtown 821 Washington Street, Boston, Massachusetts, 02111, United States

Conference Description:

Change Control Best Practices - Avoiding Unintended Consequences of Changes


*** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! ***REGISTER TODAY!

With FDA citing inadequate change control constantly in its 483s and Warning Letters, the prerequisite to ensure that changes are accurately described, justified, assessed for risk, implemented, and documented has come to the fore. Changes must also be prospectively reviewed by appropriate subject matter experts. Furthermore, certain major changes (e.g. manufacturing, specifications) may require regulatory filings and/or prior regulatory approval.

This seminar will guide all personnel involved in proposing, assessing, and implementing changes to understand and successfully apply the fundamental change control steps and best practices. The key focus will remain on:

Change proposals

Justification / risk assessment

Change execution / implementation

The seminar will focus on changes to equipment, facilities, materials/components, test methods, suppliers, specifications, etc. Document change control will be discussed as a supporting element. Additionally, this practical, how-to course will illustrate and impart:

The importance of subject matter expertise, proper planning, critical thinking skills, and co-ordination of all change activities.
Skills needed for applying change controls within an organization.
Group exercises to allow participants to practice skill sets with feedback from the instructor.
Practical training by having participant teams complete a full write-up for a mock change control.

Seminar Fee Includes:
Lunch
AM-PM Tea/Coffee
Seminar Material
USB with seminar presentation
Hard copy of presentation
Attendance Certificate
$100 Gift Cert for next seminar

Learning Objectives:

On completing this course on FDA compliance, participants will be able to:
Understand regulatory requirements and FDA expectations for change control
Understand the purpose of change control
Identify what types of changes are /are not subject to change control
Properly describe a change
Properly justify a change
Develop a comprehensive change execution plan
Conduct a proper change risk assessment
Accurately execute a change
Accurately implement a change
Develop a full change control package
Utilize critical thinking skills throughout the change control process
Avoid pitfalls during the change control process


Who Will Benefit:

This course is designed from a pharmaceutical manufacturing perspective; however, since the main focus is on techniques and practices, the course material may be equally applied to biologics and medical device environments. It will benefit:

Change proposal authors
Reviewers / approvers of change controls
Change control system owners
Production staff / management
Engineering staff / management
Validation staff /management
QA and QC staff / management
Regulatory affairs staff / management


Topic Background:

One of the top 10 FDA 483 and Warning Letter citations is for inadequate change control. Change control receives detailed scrutiny during FDA inspections, and FDA reviews change control documentation to determine that changes do not adversely impact products, processes, equipment, facilities, etc. Any individually inadequate change may lead to significant negative events, including release of sub-standard product or product recall. A pattern of inadequate changes may require costly and time-consuming system remediation efforts.


AGENDA

Day 01(8:30 AM - 4:30 PM)

08.30 AM - 09.00 AM: Registration
09.00 AM: Session Start
Regulatory Requirements
FDA Change Control Expectations / Warning Letter Examples
Purpose of Change Controls
What is Change Control?
Why Change Control?
A Different Way of Thinking
Change Control Process Model
5 Part Process Model
Key Terms and Definitions
Types of Changes Subject to Change Control
Products, Materials, Suppliers, Processes, Facilities, Equipment, etc.
Like-for-Like Changes
Change Proposal
Current State / Proposed State
Group Exercise - Change Proposal
Change Justification
Science and Compliance Rationale
Group Exercise - Change Justification
Change Execution Plan
Key Elements
Group Exercise - Change Execution Plan
Change Proposal Assessment
Risk Assessment
Validation, Technical, Regulatory, Quality Assessment
Group Exercise - Change Risk Assessment

Day 02(8:30 AM - 4:30 PM)

Executing the Change
Key Elements
Implementing the Change
Key Elements
Change Control Documentation
Key Elements
Putting It All Together: A System Viewpoint
Change Control Workshop
Participant Teams to Write-Up Mock Change Control, Based on Case Studies Provided by Trainer


SPEAKER

Andrew Campbell
Pharmaceutical Consultant - Quality & Compliance

Andrew Campbell has 25 years of pharmaceutical quality assurance and quality systems experience in both industry and consulting roles. Mr. Campbell has worked in clinical supply and commercial manufacturing environments, and has experience with integrated manufacturing and contract manufacturing business models. He has extensive expertise in the areas of deviation - CAPA, change control, GMP auditing, GMP training, and regulatory inspection preparation and management.
Working with large and small companies, Mr. Campbell has successfully developed, remediated and implemented key quality systems. He is a skilled GMP auditor, and has audited multiple API, drug product, packaging, testing, and distribution facilities. He is an experienced GMP trainer, and has developed customized and interactive training presentations for many companies. He has also provided FDA inspection support for several clients, including readiness training, on-site assistance during inspections, and authoring written responses to inspectional observations. Prior to becoming a consultant in 2007, Mr. Campbell worked for Ligand Pharmaceuticals as director of quality systems.


Please contact the event manager Marilyn ([email protected] ) below for:

- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorships
© 2024 World Conference Calendar. All rights reserved.